Erratum: IFN-γ signaling, with the synergistic contribution of TNF-α, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's diseas (Cell Death and Disease (2011) 2 (e142) 10.1038/cddis.2011.17);IFN-γ signaling, with the synergistic contribution of TNF-α, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease

Cell Death and Disease

Volumn 2, Issue 4, 2011, Pages

  Barcia, C ^a   Ros, C M ^a   Annese, V ^a   Gomez A ^a   Ros Bernal, F ^a   Aguado Year, C ^a   Martinez Pagn M E ^a   De Pablos, V ^a   Fernandez Villalba, E ^a   Herrero, M T ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

Glial cells; IFN ; Inflammation; Parkinson's disease; Pro inflammatory cytokines; TNF

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL ACTIVATION; CELL DEATH; CELL SPECIFICITY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOPAMINERGIC NERVE CELL; FEMALE; GLIA CELL; HAPLORHINI; LOW DRUG DOSE; MACACA; MALE; MEDIATOR; MICROGLIA; MOUSE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN FUNCTION; SERUM; SIGNAL TRANSDUCTION; SINGLE DRUG DOSE; SUBSTANTIA NIGRA PARS COMPACTA; ANIMAL; DISEASE MODEL; GENETICS; HUMAN; MACACA FASCICULARIS; METABOLISM; MOUSE MUTANT;

ANIMALIA; MACACA; MUS; PARKINSONIA;

ANIMALS; ASTROCYTES; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INTERFERON-GAMMA; MACACA FASCICULARIS; MALE; MICE; MICE, KNOCKOUT; MICROGLIA; PARKINSON DISEASE; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79959977446     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2012.123     Document Type: Erratum

References (40)

1. McGeer PL, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 1988; 38: 1285-1291.
2. Forno LS, DeLanney LE, Irwin I, Di Monte D, Langston JW. Astrocytes and Parkinson's disease. Prog Brain Res 1992; 94: 429-436. (Pubitemid 23026667)
3. Langston JW, Forno LS, Tetrud J, Reeves AG, Kaplan JA, Karluk D. Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine exposure. Ann Neurol 1999; 46: 598-605. (Pubitemid 29466438)
4. McGeer PL, Schwab C, Parent A, Doudet D. Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine administration. Ann Neurol 2003; 54: 599-604. (Pubitemid 37346066)
5. Barcia C, Sanchez Bahillo A, Fernandez-Villalba E, Bautista V, Poza YPM, Fernandez- Barreiro A et al. Evidence of active microglia in substantia nigra pars compacta of Parkinsonian monkeys 1 year after MPTP exposure. Glia 2004; 46: 402-409. (Pubitemid 38679198)
6. Benveniste EN, Kwon J, Chung WJ, Sampson J, Pandya K, Tang LP. Differential modulation of astrocyte cytokine gene expression by TGF-beta. J Immunol 1994; 153: 5210-5221. (Pubitemid 24356153)
7. Dickson DW, Lee SC, Mattiace LA, Yen SH, Brosnan C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 1993; 7: 75-83.
8. Mount MP, Lira A, Grimes D, Smith PD, Faucher S, Slack R et al. Involvement of interferongamma in microglial-mediated loss of dopaminergic neurons. J Neurosci 2007; 27: 3328-3337. (Pubitemid 46474138)
9. Reale M, Iarlori C, Thomas A, Gambi D, Perfetti B, Di Nicola M et al. Peripheral cytokines profile in Parkinson's disease. Brain Behav Immun 2009; 23: 55-63.
10. Mogi M, Harada M, Riederer P, Narabayashi H, Fujita K, Nagatsu T. Tumor necrosis factoralpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from Parkinsonian patients. Neurosci Lett 1994; 165: 208-210.
11. Sriram K, Matheson JM, Benkovic SA, Miller DB, Luster MI, O'Callaghan JP. Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease. FASEB J 2002; 16: 1474-1476.
12. Ferger B, Leng A, Mura A, Hengerer B, Feldon J. Genetic ablation of tumor necrosis factoralpha (TNF-alpha) and pharmacological inhibition of TNF-synthesis attenuates MPTP toxicity in mouse striatum. J Neurochem 2004; 89: 822-833. (Pubitemid 38684730)
13. Barcia C, de Pablos V, Bautista-Hernandez V, Sanchez-Bahillo A, Bernal I, Fernandez- Villalba E et al. Increased plasma levels of TNF-alpha but not of IL1-beta in MPTP-treated monkeys one year after the MPTP administration. Parkinsonism Relat Disord 2005; 11: 435-439. (Pubitemid 41526994)
14. Vazquez-Claverie M, Garrido-Gil P, San Sebastian W, Izal-Azcarate A, Belzunegui S, Marcilla I et al. Acute and chronic 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine administrations elicit similar microglial activation in the substantia nigra of monkeys. J Neuropathol Exp Neurol 2009; 68: 977-984.
15. Hashioka S, Klegeris A, Schwab C, McGeer PL. Interferon-gamma-dependent cytotoxic activation of human astrocytes and astrocytoma cells. Neurobiol Aging 2009; 30: 1924-1935.
16. Tsuda M, Masuda T, Kitano J, Shimoyama H, Tozaki-Saitoh H, Inoue K. IFN-gamma receptor signaling mediates spinal microglia activation driving neuropathic pain. Proc Natl Acad Sci USA 2009; 106: 8032-8037.
17. Vega C, Pellerin L, Dantzer R, Magistretti PJ. Long-term modulation of glucose utilization by IL-1 alpha and TNF-alpha in astrocytes: Na+ pump activity as a potential target via distinct signaling mechanisms. Glia 2002; 39: 10-18.
18. Kipp M, Karakaya S, Johann S, Kampmann E, Mey J, Beyer C. Oestrogen and progesterone reduce lipopolysaccharide-induced expression of tumour necrosis factoralpha and interleukin-18 in midbrain astrocytes. J Neuroendocrinol 2007; 19: 819-822. (Pubitemid 47386883)
19. Lung HL, Leung KN, Stadlin A, Ma CM, Tsang D. Induction of tumor necrosis factor receptor type 2 gene expression by tumor necrosis factor-alpha in rat primary astrocytes. Life Sci 2001; 68: 2081-2091. (Pubitemid 32289390)
20. Scalzo P, Kummer A, Cardoso F, Teixeira AL. Increased serum levels of soluble tumor necrosis factor-alpha receptor-1 in patients with Parkinson's disease. J Neuroimmunol 2009; 216: 122-125.
21. Godoy MC, Tarelli R, Ferrari CC, Sarchi MI, Pitossi FJ. Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease. Brain 2008; 131 (Part 7): 1880-1894. (Pubitemid 351957456)
22. Kurkowska-Jastrzebska I, Balkowiec-Iskra E, Ciesielska A, Joniec I, Cudna A, Zaremba MM et al. Decreased inflammation and augmented expression of trophic factors correlate with MOG-induced neuroprotection of the injured nigrostriatal system in the murine MPTP model of Parkinson's disease. Int Immunopharmacol 2009; 9: 781-791.
23. Luchtman DW, Shao D, Song C. Behavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson's disease. Physiol Behav 2009; 98: 130-138.
24. Hebert G, Arsaut J, Dantzer R, Demotes-Mainard J. Time-course of the expression of inflammatory cytokines and matrix metalloproteinases in the striatum and mesencephalon of mice injected with 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine, a dopaminergic neurotoxin. Neurosci Lett 2003; 349: 191-195. (Pubitemid 37297810)
25. Brochard V, Combadiere B, Prigent A, Laouar Y, Perrin A, Beray-Berthat V et al. Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease. J Clin Invest 2009; 119: 182-192.
26. Bogdan C, Schleicher U. Production of interferon-gamma by myeloid cells-fact or fancy? Trends Immunol 2006; 27: 282-290. (Pubitemid 43850405)
27. Puddu P, Fantuzzi L, Borghi P, Varano B, Rainaldi G, Guillemard E et al. IL-12 induces IFN-gamma expression and secretion in mouse peritoneal macrophages. J Immunol 1997; 159: 3490-3497. (Pubitemid 127482108)
28. Munder M, Mallo M, Eichmann K, Modolell M. Murine macrophages secrete interferon gamma upon combined stimulation with interleukin (IL)-12 and IL-18: a novel pathway of autocrine macrophage activation. J Exp Med 1998; 187: 2103-2108. (Pubitemid 28285581)
29. Saijo K, Winner B, Carson CT, Collier JG, Boyer L, Rosenfeld MG et al. A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammationinduced death. Cell 2009; 137: 47-59.
30. Downen M, Amaral TD, Hua LL, Zhao ML, Lee SC. Neuronal death in cytokine-activated primary human brain cell culture: role of tumor necrosis factor-alpha. Glia 1999; 28: 114-127. (Pubitemid 29530610)
31. Boka G, Anglade P, Wallach D, Javoy-Agid F, Agid Y, Hirsch EC. Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease. Neurosci Lett 1994; 172: 151-154. (Pubitemid 24178765)
32. Chen H, Jacobs E, Schwarzschild MA, McCullough ML, Calle EE, Thun MJ et al. Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease. Ann neurol 2005; 58: 963-967. (Pubitemid 41746889)
33. Hamza TH, Zabetian CP, Tenesa A, Laederach A, Montimurro J, Yearout D et al. Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat genet 2010; 42: 781-785.
34. Kopf M, Bachmann MF, Marsland BJ. Averting inflammation by targeting the cytokine environment. Nat rev 2010; 9: 703-718.
35. Herrero MT, Hirsch EC, Kastner A, Ruberg M, Luquin MR, Laguna J et al. Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP? Neuroscience 1993; 56: 499-511. (Pubitemid 23274767)
36. Paxinos GC, Franklin KBJ. The mouse brain in stereotaxic coordinates. Academic Press: New York, 2001.
37. Paxinos G, Xu-Feng H, Toga A. The Rhesus Monkey Brain in Stereotaxic Coordinates. Academic Press: San Diego, 1999.
38. Olzewski J., Baxter D. In: Boyd JD (ed.). Cytoarchitecture of the Human Brainstem S. Karger, Lippincott Company: Philadelphia and Montreal, 1954.
39. Damier P, Hirsch EC, Agid Y, Graybiel AM. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain 1999; 122 (Part 8): 1437-1448. (Pubitemid 29374122)
40. Barcia C, Thomas CE, Curtin JF, King GD, Wawrowsky K, Candolfi M et al. In vivo mature immunological synapses forming SMACs mediate clearance of virally infected astrocytes from the brain. J Exp Med 2006; 203: 2095-2107.